Market-Beating Community Intelligence
Results 51 - 60 of 757 : Previous 2 3 4 5 6 7 8 9 10 Next
Whoa! My Stock Just Crushed the Market!
These stocks just took off, but are they about to make a return trip to Earth?
Who's Next on Hep C Biotech Buyout Hit List?
one of the big questions on everyone's mind after Gilead Sciences announced its deal to acquire Pharmasset is, "Who's next?"
2-Star Stocks Poised to Plunge: AMAG Pharmaceuticals?
Market-lagging returns could be written in these two stars.
Market Volatility = Biotech Opportunity
Gilead buys Pharmasset, Spectrum gets a break, and Eylea's approved.
Pharmasset Acquired, Shares Jump 85%
Gilead Sciences buys Pharmasset and hepatitis C drug PSI-7977.
Inhibitex Shares Surged: What You Need to Know
Is this meaningful? Or just another movement?
Gilead Sciences Shares Plunged: What You Need to Know
Is this meaningful or just another movement?
Pharmasset Shares Skyrocketed: What You Need to Know
Is this meaningful? Or just another movement?
Why Amgen's Earnings Are Outstanding
All cash flow is not created equal.
The Only Way to Survive in This Drug Market
Gilead and J&J sign another pact.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK